Cafepharma Today

May 20 2019 - Mylan pays $130M for basket of Aspen Pharmacare drugs
Mylan pays $130M for basket of Aspen Pharmacare drugs
Industry steps up interest in developing countries
AZ’s Fasenra offers severe asthma patients 2 years of benefits
How big pharma both repels and embraces innovation
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

NEW board: ASK A WHISTLEBLOWER ATTORNEY
Today's most popular searches:

Current News

submit a press release
SPOTLIGHT on: CP's Therapeutic Specialties Messageboards
Gilead struck anti-competitive deals to bolster profits on an HIV drug, lawsuit says
Stat
Tuesday, May 14, 2019 - 11:39pm
tags:
Gilead Sciences, AIDS, HIV, generics, competition
Solid Biosciences’ Duchenne Muscular Dystrophy Drug Has Side Effect Issues
BioSpace
Tuesday, May 14, 2019 - 11:37pm
tags:
Solid Biosciences, Duchenne Muscular Dystrophy
Merck KGaA retools F-star pact, walks away from lead PD-L1 drug
Fierce Biotech
Tuesday, May 14, 2019 - 11:36pm
tags:
Merck KGaA, bispecific antibodies, f-star, drug discovery
Almost Half of All New Drug Approvals in 2018 Relied on One Clinical Trial
RAPS.org
Tuesday, May 14, 2019 - 5:05pm
tags:
drug approvals, FDA, clinical trials
Novartis' Sandoz does digital from back office to 'not just apps' therapeutics
Fierce Pharma
Tuesday, May 14, 2019 - 5:04pm
tags:
digital pharma, Sandoz, Novartis
Why MannKind Is Up Big Today
Motley Fool
Tuesday, May 14, 2019 - 5:00pm
tags:
MannKind, inhaled insulin, Afrezza
Zealand’s Severe Hypoglycemia Treatment Hits the Mark in Another Phase III Trial
BioSpace
Tuesday, May 14, 2019 - 4:58pm
tags:
Zealand Pharma, hypoglycemia, dasiglucagon, HypoPal
How can Teva's migraine drug face off Amgen and Lilly? Put neurologists first, DTC last, executive says
Fierce Pharma
Tuesday, May 14, 2019 - 4:55pm
tags:
Teva Pharmaceutical, migraines, Ajovy, Amgen, Eli Lilly, Emgality, Aimovig, neurologists, physicians, DTC advertising
What's taking the FTC so long? Roche won't say, but insists it will bag Spark on time — despite third delay
Endpoints
Tuesday, May 14, 2019 - 11:05am
tags:
Roche, Spark Therapeutics, M&A
FDA approves Regeneron’s Eylea for diabetic retinopathy
Pharmaforum
Tuesday, May 14, 2019 - 9:58am
tags:
Regeneron, Eylea, diabetic retinopathy, FDA, Bayer
Alzheimer’s R&D projects sidelined as Biogen’s aducanumab shock shakes researchers to the core of their beliefs
Endpoints
Tuesday, May 14, 2019 - 9:56am
tags:
Alzheimer's disease, drug development, aducanumab, Biogen, Eisai, BAN2401, Merck, Eli Lilly, AstraZeneca
EXCLUSIVE: 340B Program Purchases Reach $24.3 Billion—7%+ of the Pharma Market—As Hospitals’ Charity Care Flatlines
Drug Channels
Tuesday, May 14, 2019 - 9:55am
tags:
drug pricing, 340B
Pfizer selects first GPCR candidate from Sosei Heptares tie-up
Pharmaforum
Tuesday, May 14, 2019 - 9:53am
tags:
Pfizer, Sosei Heptares, drug development, R&D, GPCRs
A new study sparks a war of words over the drug industry’s commitment to research
Stat
Tuesday, May 14, 2019 - 9:51am
tags:
R&D, drug development
Bicycle Therapeutics Updates Filing for $80 Million IPO
CP Wire
Tuesday, May 14, 2019 - 9:33am
tags:
Bicycle Therapeutics, IPOs, drug development
AbbVie stock up 1.3% after announcing resolution to litigation over Humira in the U.S.
Marketwatch
Tuesday, May 14, 2019 - 9:31am
tags:
AbbVie, biosimilars, Humira, patents, Boehringer Ingelheim
Dr. Reddy's (RDY) to Report Q4 Earnings: What's in Store?
Yahoo/Zacks.com
Tuesday, May 14, 2019 - 9:29am
tags:
Dr Reddy's, earnings
Myovant hits goal in uterine fibroid phase 3, teeing up AbbVie showdown
Fierce Biotech
Tuesday, May 14, 2019 - 9:26am
tags:
Myovant Sciences, Relugolix, clinical trials, uterine fibroids, AbbVie, Elagolix
Sunovion’s SEP-363856 gets FDA breakthrough status for schizophrenia
Pharmaceutical Business Review
Tuesday, May 14, 2019 - 9:24am
tags:
Sunovion, PsychoGenics, breakthrough therapies, SEP-363856, schizophrenia
Celgene gets FDA breakthrough therapy designation for Pomalyst to treat Kaposi sarcoma
Pharmaceutical Business Review
Tuesday, May 14, 2019 - 9:23am
tags:
Celgene, Pomalyst, breakthrough therapies, Kaposi's Sarcoma

Pages

Latest CP Wire Articles

Health Analytics Hires New Chief Operating Officer Strengthening Payer Perspective in Health Economics and Outcomes Research
Life Science VC Firm Launches Quell with $43 Million Series A Round
Highlights: 2019 Cardiometabolic Health Congress West
Microbiome Report for Week Ending 5/11/19
Aeneas Capital and Pyrinas Realestate Management Partner to Launch $120m Fund to Develop Laboratory Space for Life Sciences Start-Ups in the US
Bicycle Therapeutics Updates Filing for $80 Million IPO
Microbiome Report for Week Ending 5/4/19
Oramed spearheading human oral insulin trials in 37 US centers
Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings
Twist Bioscience Files for $85 Million Offering of Common Stock

Latest Pharmagather Articles

Absolute Configuration With Electrons
In the Pipeline
Reimbursement and Access 2019
Drug Channels
Myristoylation Probes, Rethought
In the Pipeline
Honing Reforms from Clinical Development
pharmexec sales
GSK Rethinks Rep Compensation
pharmexec sales
Physicians Not on the Move
pharmexec sales
The 2010 Pharm Exec 50 (pdf)
pharmexec sales
Pfizer and Merck: Bullets Dodged
pharmexec sales
Biotech Industry Profits Grow $3.7B
pharmexec sales
Pharma Jobs from Indeed

Pharma and Device News from NASDAQ

Arrayit Corporation Aces Fifth Consecutive Proficiency Testing Round with a Top Laboratory Medicine Proficiency Testing Leader
Monday, May 20, 2019 - 5:30am
Intrommune Therapeutics Receives Best Private Company Presentation Award at BioNJ’s 9th Annual BioPartnering Conference
Friday, May 17, 2019 - 1:25pm
World Fuel to Supply Gevo’s Sustainable Jet Fuel for First of its Kind European Demonstration Event
Friday, May 17, 2019 - 9:00am
LifeVantage Honored as Stevie® Award Winner in 2019 American Business Awards
Friday, May 17, 2019 - 8:00am
CytoDyn to Hold Investment Community Conference Call on May 20, 2019
Thursday, May 16, 2019 - 9:40am
Geron Announces Two Presentations on Imetelstat at Upcoming European Hematology Association Annual Congress
Thursday, May 16, 2019 - 9:05am
Gevo and Avfuel Supply Sustainable Alternative Jet Fuel for Transatlantic Operators Headed to EBACE
Thursday, May 16, 2019 - 9:00am
Adverum Biotechnologies Provides Update on OPTIC Phase 1 Trial for ADVM-022 in Wet AMD
Thursday, May 16, 2019 - 9:00am
Corvus Pharmaceuticals to Present Initial Clinical Data from CPI-006 Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Thursday, May 16, 2019 - 8:30am
Geron Provides Imetelstat Program Update
Thursday, May 16, 2019 - 8:00am

Breaking Healthcare News - powered by Seeking Alpha

Can-Fite BioPharma leads healthcare gainers; MediciNova and INSYS Therapeutics among losers
Monday, May 20, 2019 - 11:02am
Principia Bio's cancer candidate PRN1371 shows encouraging action in early-stage study
Monday, May 20, 2019 - 9:59am
BioXcel's lead drug shows favorable profile in early-stage study
Monday, May 20, 2019 - 9:38am
Amyris pockets $10M milestone from LAVVAN
Monday, May 20, 2019 - 9:20am
Can-Fite up 5% premarket on namodenonson progress
Monday, May 20, 2019 - 9:08am
Biocept up 28% premarket on launch of lung cancer test
Monday, May 20, 2019 - 8:58am
Health Canada grants Emerald Health processing license for Delta 3 greenhouse facility
Monday, May 20, 2019 - 8:50am
Innovate Biopharma -3.8% on holders' offering of 15.1M shares
Friday, May 17, 2019 - 6:04pm
GlycoMimetics files for $250M mixed shelf
Friday, May 17, 2019 - 4:37pm
Halo Labs converts debt to shares
Friday, May 17, 2019 - 4:30pm

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.